PubMed

Substance use treatment barriers for patients with frequent hospital admissions.

Raven MC, Carrier ER, Lee J, Billings JC, Marr M, Gourevitch MN.

J Subst Abuse Treat. 2009 Jun 19. [Epub ahead of print]PMID: 19540700 [PubMed - as supplied by publisher]Related articles

Medical homes: challenges in translating theory into practice.

Carrier E, Gourevitch MN, Shah NR.

Med Care. 2009 Jul;47(7):714-22. Review.PMID: 19536005 [PubMed - indexed for MEDLINE]Related articles

First do no harm ... Reduction?

Gourevitch MN.

Ann Intern Med. 2009 Mar 17;150(6):417-8. Epub 2009 Feb 18. No abstract available. PMID: 19225161 [PubMed - indexed for MEDLINE]Related articlesFree article

Home buprenorphine/naloxone induction in primary care.

Lee JD, Grossman E, DiRocco D, Gourevitch MN.

J Gen Intern Med. 2009 Feb;24(2):226-32. Epub 2008 Dec 17.PMID: 19089508 [PubMed - indexed for MEDLINE]Related articles

Medicaid patients at high risk for frequent hospital admission: real-time identification and remediable risks.

Raven MC, Billings JC, Goldfrank LR, Manheimer ED, Gourevitch MN.

J Urban Health. 2009 Mar;86(2):230-41. Epub 2008 Dec 12.PMID: 19082899 [PubMed - indexed for MEDLINE]Related articles

Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program.

Litwin AH, Harris KA Jr, Nahvi S, Zamor PJ, Soloway IJ, Tenore PL, Kaswan D, Gourevitch MN, Arnsten JH.

J Subst Abuse Treat. 2009 Jul;37(1):32-40. Epub 2008 Nov 28.PMID: 19038524 [PubMed - indexed for MEDLINE]Related articles

Update in addiction medicine for the primary care clinician.

Gordon AJ, Fiellin DA, Friedmann PD, Gourevitch MN, Kraemer KL, Arnsten JH, Saitz R; Society of General Internal Medicine's Substance Abuse Interest Group.

J Gen Intern Med. 2008 Dec;23(12):2112-6. Epub 2008 Oct 2. Review. No abstract available. PMID: 18830761 [PubMed - indexed for MEDLINE]Related articles

Validation of the Spanish translation of the Patient Assessment of Chronic Illness Care (PACIC) survey.

Aragones A, Schaefer EW, Stevens D, Gourevitch MN, Glasgow RE, Shah NR.

Prev Chronic Dis. 2008 Oct;5(4):A113. Epub 2008 Sep 15.PMID: 18793501 [PubMed - indexed for MEDLINE]Related articlesFree article

Factors affecting willingness to provide buprenorphine treatment.

Netherland J, Botsko M, Egan JE, Saxon AJ, Cunningham CO, Finkelstein R, Gourevitch MN, Renner JA, Sohler N, Sullivan LE, Weiss L, Fiellin DA; BHIVES Collaborative.

J Subst Abuse Treat. 2009 Apr;36(3):244-51. Epub 2008 Aug 20.PMID: 18715741 [PubMed - indexed for MEDLINE]Related articles

Working with patients with alcohol problems: a controlled trial of the impact of a rich media web module on medical student performance.

Lee JD, Triola M, Gillespie C, Gourevitch MN, Hanley K, Truncali A, Zabar S, Kalet A.

J Gen Intern Med. 2008 Jul;23(7):1006-9.PMID: 18612733 [PubMed - indexed for MEDLINE]Related articlesFree article

The public hospital in American medical education.

Gourevitch MN, Malaspina D, Weitzman M, Goldfrank LR.

J Urban Health. 2008 Sep;85(5):779-86. Epub 2008 Jun 24.PMID: 18575982 [PubMed - indexed for MEDLINE]Related articlesFree article

Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users.

Arnsten JH, Li X, Mizuno Y, Knowlton AR, Gourevitch MN, Handley K, Knight KR, Metsch LR; for the INSPIRE Study Team.

J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S64-71.PMID: 18089986 [PubMed - indexed for MEDLINE]Related articles

Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users.

Purcell DW, Latka MH, Metsch LR, Latkin CA, Gómez CA, Mizuno Y, Arnsten JH, Wilkinson JD, Knight KR, Knowlton AR, Santibanez S, Tobin KE, Rose CD, Valverde EE, Gourevitch MN, Eldred L, Borkowf CB; for the INSPIRE Study Team.

J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S35-47.PMID: 18089983 [PubMed - indexed for MEDLINE]Related articles

Longitudinal correlates of health care-seeking behaviors among HIV-seropositive injection drug users: how can we intervene to improve health care utilization?

Wilkinson JD, Zhao W, Arnsten JH, Knowlton AR, Mizuno Y, Shade SB, Gourevitch MN, Santibanez S, Metsch LR; for the INSPIRE Study Team.

J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S120-6.PMID: 18089981 [PubMed - indexed for MEDLINE]Related articles

Microsocial environmental influences on highly active antiretroviral therapy outcomes among active injection drug users: the role of informal caregiving and household factors.

Knowlton AR, Arnsten JH, Gourevitch MN, Eldred L, Wilkinson JD, Rose CD, Buchanan A, Purcell DW; INSPIRE Study Team.

J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S110-9.PMID: 18089980 [PubMed - indexed for MEDLINE]Related articles

Two-step tuberculin skin testing in drug users.

Swaminathan S, Schoenbaum EE, Klein RS, Howard AA, Lo Y, Gourevitch MN.

J Addict Dis. 2007;26(2):71-9.PMID: 17595000 [PubMed - indexed for MEDLINE]Related articles

Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.

Whitley SD, Kunins HV, Arnsten JH, Gourevitch MN.

J Subst Abuse Treat. 2007 Jul;33(1):85-90. Epub 2007 Jan 9.PMID: 17588493 [PubMed - indexed for MEDLINE]Related articles

Update in addiction medicine for the generalist.

Gordon AJ, Sullivan LE, Alford DP, Arnsten JH, Gourevitch MN, Kertesz SG, Kunins HV, Merrill JO, Samet JH, Fiellin DA.

J Gen Intern Med. 2007 Aug;22(8):1190-4. Epub 2007 May 10. Review. No abstract available. PMID: 17492327 [PubMed - indexed for MEDLINE]Related articlesFree article

Hepatitis C management by addiction medicine physicians: results from a national survey.

Litwin AH, Kunins HV, Berg KM, Federman AD, Heavner KK, Gourevitch MN, Arnsten JH.

J Subst Abuse Treat. 2007 Jul;33(1):99-105. Epub 2007 Mar 26.PMID: 17379472 [PubMed - indexed for MEDLINE]Related articles

Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: a prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment.

Berk SI, Litwin AH, Arnsten JH, Du E, Soloway I, Gourevitch MN.

Clin Ther. 2007 Jan;29(1):131-8.PMID: 17379053 [PubMed - indexed for MEDLINE]Related articles

On-site medical care in methadone maintenance: associations with health care use and expenditures.

Gourevitch MN, Chatterji P, Deb N, Schoenbaum EE, Turner BJ.

J Subst Abuse Treat. 2007 Mar;32(2):143-51. Epub 2006 Oct 27.PMID: 17306723 [PubMed - indexed for MEDLINE]Related articles

Opioid dependence: rationale for and efficacy of existing and new treatments.

Fiellin DA, Friedland GH, Gourevitch MN.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S173-7. Review.PMID: 17109303 [PubMed - indexed for MEDLINE]Related articles

A 5-year evaluation of a methadone medical maintenance program.

Harris KA Jr, Arnsten JH, Joseph H, Hecht J, Marion I, Juliana P, Gourevitch MN.

J Subst Abuse Treat. 2006 Dec;31(4):433-8. Epub 2006 Sep 7.PMID: 17084798 [PubMed - indexed for MEDLINE]Related articlesFree article

Safe syringe disposal is related to safe syringe access among HIV-positive injection drug users.

Coffin PO, Latka MH, Latkin C, Wu Y, Purcell DW, Metsch L, Gomez C, Gourevitch MN; INSPIRE Study Group.

AIDS Behav. 2007 Sep;11(5):652-62. Epub 2006 Oct 12.PMID: 17053854 [PubMed - indexed for MEDLINE]Related articles

False reduction in serum methadone concentrations by BD Vacutainer serum separator tubes (SSTTM).

Berk SI, Litwin AH, Du Y, Cruikshank G, Gourevitch MN, Arnsten JH.

Clin Chem. 2006 Oct;52(10):1972-4. No abstract available. PMID: 16998122 [PubMed - indexed for MEDLINE]Related articlesFree article

Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment.

McNeely J, Arnsten JH, Gourevitch MN.

J Subst Abuse Treat. 2006 Jul;31(1):51-7.PMID: 16814010 [PubMed - indexed for MEDLINE]Related articles

Correlates of health care utilization among HIV-seropositive injection drug users.

Mizuno Y, Wilkinson JD, Santibanez S, Dawson Rose C, Knowlton A, Handley K, Gourevitch MN; Inspire Team.

AIDS Care. 2006 Jul;18(5):417-25.PMID: 16777632 [PubMed - indexed for MEDLINE]Related articles

Unprotected sex among HIV-positive injection drug-using women and their serodiscordant male partners: role of personal and partnership influences.

Latka MH, Metsch LR, Mizuno Y, Tobin K, Mackenzie S, Arnsten JH, Gourevitch MN.

J Acquir Immune Defic Syndr. 2006 Jun;42(2):222-8.PMID: 16760799 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice.

Bruce RD, Altice FL, Gourevitch MN, Friedland GH.

J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):563-72. Review.PMID: 16652030 [PubMed - indexed for MEDLINE]Related articles

Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users.

Shah SS, McGowan JP, Klein RS, Converse PJ, Blum S, Gourevitch MN.

Med Sci Monit. 2006 Apr;12(4):MT11-6. Epub 2006 Mar 28.PMID: 16572060 [PubMed - indexed for MEDLINE]Related articles

Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey.

McNeely J, Arnsten JH, Gourevitch MN.

Harm Reduct J. 2006 Feb 18;3:8.PMID: 16503997 [PubMed]Related articlesFree article

Effects of methadone on QT-interval dispersion.

Krantz MJ, Lowery CM, Martell BA, Gourevitch MN, Arnsten JH.

Pharmacotherapy. 2005 Nov;25(11):1523-9.PMID: 16232014 [PubMed - indexed for MEDLINE]Related articles

Economic evaluation of an HIV prevention intervention for seropositive injection drug users.

Tuli K, Sansom S, Purcell DW, Metsch LR, Latkin CA, Gourevitch MN, Gómez CA; INSPIRE Team.

J Public Health Manag Pract. 2005 Nov-Dec;11(6):508-15.PMID: 16224285 [PubMed - indexed for MEDLINE]Related articles

The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone.

Sylvestre DL, Litwin AH, Clements BJ, Gourevitch MN.

J Subst Abuse Treat. 2005 Oct;29(3):159-65.PMID: 16183464 [PubMed - indexed for MEDLINE]Related articles

Impact of methadone treatment on cardiac repolarization and conduction in opioid users.

Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN.

Am J Cardiol. 2005 Apr 1;95(7):915-8.PMID: 15781034 [PubMed - indexed for MEDLINE]Related articles

Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.

Litwin AH, Soloway I, Gourevitch MN.

Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S339-45.PMID: 15768345 [PubMed - indexed for MEDLINE]Related articles

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, Cheever LW, Cargill VA.

Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S276-85. Review.PMID: 15768335 [PubMed - indexed for MEDLINE]Related articlesFree article

Gender differences in factors associated with adherence to antiretroviral therapy.

Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH.

J Gen Intern Med. 2004 Nov;19(11):1111-7.PMID: 15566440 [PubMed - indexed for MEDLINE]Related articlesFree article

Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection.

Fishbein DA, Lo Y, Reinus JF, Gourevitch MN, Klein RS.

J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1367-75.PMID: 15483466 [PubMed - indexed for MEDLINE]Related articles

Validity of a self-reported history of a positive tuberculin skin test. A prospective study of drug users.

Kunins HV, Howard AA, Klein RS, Arnsten JH, Litwin AH, Schoenbaum EE, Gourevitch MN.

J Gen Intern Med. 2004 Oct;19(10):1039-44.PMID: 15482557 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of alcohol consumption on diabetes mellitus: a systematic review.

Howard AA, Arnsten JH, Gourevitch MN.

Ann Intern Med. 2004 Feb 3;140(3):211-9. Review.PMID: 14757619 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.

Scholten JN, Driver CR, Munsiff SS, Kaye K, Rubino MA, Gourevitch MN, Trim C, Amofa J, Seewald R, Highley E, Fujiwara PI.

Clin Infect Dis. 2003 Dec 15;37(12):1686-92. Epub 2003 Nov 17.PMID: 14689352 [PubMed - indexed for MEDLINE]Related articles

Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy.

Floris-Moore M, Lo Y, Klein RS, Budner N, Gourevitch MN, Moskaleva G, Schoenbaum EE.

J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):331-7.PMID: 14600580 [PubMed - indexed for MEDLINE]Related articles

Medications that prolong the QT interval.

Krantz MJ, Martell BA, Arnsten JH, Gourevitch MN.

JAMA. 2003 Aug 27;290(8):1025; author reply 1026. No abstract available. PMID: 12941668 [PubMed - indexed for MEDLINE]Related articles

The impact of methadone induction on cardiac conduction in opiate users.

Martell BA, Arnsten JH, Ray B, Gourevitch MN.

Ann Intern Med. 2003 Jul 15;139(2):154-5. No abstract available. PMID: 12859171 [PubMed - indexed for MEDLINE]Related articlesFree article

Modified directly observed therapy (MDOT) for injection drug users with HIV disease.

McCance-Katz EF, Gourevitch MN, Arnsten J, Sarlo J, Rainey P, Jatlow P.

Am J Addict. 2002 Fall;11(4):271-8.PMID: 12584870 [PubMed - indexed for MEDLINE]Related articles

Crack cocaine use and other risk factors for tuberculin positivity in drug users.

Howard AA, Klein RS, Schoenbaum EE, Gourevitch MN.

Clin Infect Dis. 2002 Nov 15;35(10):1183-90. Epub 2002 Oct 25.PMID: 12410478 [PubMed - indexed for MEDLINE]Related articles

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, Schoenbaum EE.

J Gen Intern Med. 2002 May;17(5):377-81.PMID: 12047736 [PubMed - indexed for MEDLINE]Related articlesFree article

Analysis of a population-based Pneumocystis carinii pneumonia index as an outcome measure of access and quality of care for the treatment of HIV disease.

Arno PS, Gourevitch MN, Drucker E, Fang J, Goldberg C, Memmott M, Bonuck K, Deb N, Schoenbaum E.

Am J Public Health. 2002 Mar;92(3):395-8.PMID: 11867318 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.

Perlman DC, Gourevitch MN, Trinh C, Salomon N, Horn L, Des Jarlais DC.

J Urban Health. 2001 Sep;78(3):550-67.PMID: 11564856 [PubMed - indexed for MEDLINE]Related articles